Ferric Citrate Tablets 210mg
Ferric Citrate Tablets are phosphate binders used to control high phosphate levels in chronic kidney disease. They also help increase iron stores and support better hemoglobin management.
Brand Name: FEBGOL
Generic Name: Ferric Citrate Tablets
Available Strengths:
Ferric Citrate Tablets 210mg
Ferric Citrate Tablets are an effective oral phosphate binder specially formulated for patients with chronic kidney disease (CKD), particularly those undergoing dialysis. By binding dietary phosphate in the gastrointestinal tract, Ferric Citrate helps reduce elevated serum phosphate levels and maintain healthy mineral balance. Additionally, the ferric iron content supports improved iron stores and may contribute to enhanced hemoglobin levels in anemic CKD patients. These tablets offer dual benefits—phosphate control and iron supplementation—making them a valuable therapeutic option in renal care. Manufactured under strict pharmaceutical quality standards, Ferric Citrate Tablets ensure high purity, consistent performance, and reliable clinical outcomes.
Capabilities Offered:
Ready dossier for both strengths in CTD/ ACTD format
Third party manufacturing services
Contract Manufacturing (CMO Services)
Formulation Development Services
Regulatory & Documentation Support
Export / Licensing Services
In addition to the products listed on our website, we possess the technical capability and infrastructure to develop and manufacture customized formulations as per your specific requirements and regulatory markets.
For business inquiries, email at sales@cooperpharma.com